Semnur Pharmaceuticals, Inc. (SMNRW) Net income 2022–2025
Semnur Pharmaceuticals, Inc. (SMNRW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$160.4MFY2025 · since FY2022: -$419,390 → -$160.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.4M | -3320.4% |
| FY2024 | -$4.7M | -841.5% |
| FY2023 | $632,536 | +250.8% |
| FY2022 | -$419,390 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNRW financial trends
SMNRW RevenueSMNRW Net marginSMNRW Gross profitSMNRW Gross marginSMNRW Operating incomeSMNRW Operating marginSMNRW Operating cash flowSMNRW Free cash flowSMNRW Capital expendituresSMNRW Return on equitySMNRW Stock buybacksSMNRW Dividends paidSMNRW Total assetsSMNRW Total liabilitiesSMNRW Shareholders’ equitySMNRW overview →